Yüklüyor......
The Discovery and Development of Liraglutide and Semaglutide
The discovery of glucagon-like peptide-1 (GLP-1), an incretin hormone with important effects on glycemic control and body weight regulation, led to efforts to extend its half-life and make it therapeutically effective in people with type 2 diabetes (T2D). The development of short- and then long-acti...
Kaydedildi:
| Yayımlandı: | Front Endocrinol (Lausanne) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6474072/ https://ncbi.nlm.nih.gov/pubmed/31031702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00155 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|